Sanofi said it will repurchase €5 billion ($5.2 billion) of stock and grow profits faster this year as the drugmaker pivots away from consumer health to focus on fast-growing drugs like its RSV shot.M ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback